RNA, U6 small nuclear 609, pseudogene (RNU6-609P)

RNU6-609P (RNA, U6 small nuclear 609, pseudogene) is a genomic sequence derived from the U6 small nuclear RNA gene, but is annotated as a pseudogene, meaning it does not encode a functional product. The parent molecule, U6 snRNA, forms part of the spliceosome, an essential ribonucleoprotein complex responsible for pre-mRNA splicing in eukaryotes[3][1]. Pseudogenes such as RNU6-609P may be transcribed and can sometimes participate in gene regulation by acting as antisense RNAs, microRNA decoys, or competing endogenous RNAs, but the functional significance of this particular pseudogene is unknown[2][3]. There is no evidence that RNU6-609P serves as a drug target, a disease biomarker, or has recognized biological or clinical importance. Notes on correctness: - RNU6-609P is a pseudogene, not an active molecular target. - It is not a receptor, enzyme, or therapeutic target. - There is little to no information about specific biological or disease roles. - Therefore, it should not be considered a canonical drug target or structured entry for pharmacological profiling. If you need information on the functional "U6 small nuclear RNA," see U6 snRNA or RNU6-1, which is the active component of the spliceosome[3][1].

Other names

RNU6-609PRNA, U6 small nuclear 609 pseudogene

None known; pseudogenes are not directly targeted by drugs[2].